Literature DB >> 2449460

Schistosoma japonicum egg antigen-specific T cell lines in man. Induction of helper and suppressor T cell lines and clones in vitro in a patient with chronic schistosomiasis japonica.

N Ohta1, T Itagaki, M Minai, K Hirayama, Y Hosaka.   

Abstract

T cell lines (TCLs) specific for Schistosoma japonicum egg antigen were established from a patient with chronic schistosomiasis japonica to investigate the regulatory mechanism of S.japonicum egg antigen-driven T cell responses in man. All five TCLs tested were CD2+, CD4+, CD8-, and were strongly proliferative only to S. japonicum egg antigen in the absence of exogenous IL-2. All but one TCL produced IL-2-like lymphokines in vitro, indicating their helper T cell functions. One TCL, SjE-3, failed to produce IL-2-like lymphokines. Moreover, this TCL suppressed the specific proliferation of autologous peripheral blood lymphocytes to S. japonicum egg antigen. This TCL produced a soluble suppressor factor(s). These functional diversities among established TCLs were also confirmed by cloned T cells. Our observations might suggest that the regulatory system through helper and suppressor T-T interactions somehow involved in T cell responses to the egg antigen in human chronic schistosomiasis japonica.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2449460      PMCID: PMC442525          DOI: 10.1172/JCI113383

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Suppressor cell induction in vitro. II. Cellular requirements of suppressor cell induction.

Authors:  M Feldmann; S Kontiainen
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

2.  Filarial parasite-specific T cell lines: induction of IgE synthesis.

Authors:  T B Nutman; D J Volkman; R Hussain; A S Fauci; E A Ottesen
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

Review 3.  Immunoregulation in chronic infectious disease: schistosomiasis as a model.

Authors:  R P Pelley; K S Warren
Journal:  J Invest Dermatol       Date:  1978-07       Impact factor: 8.551

4.  Cellular basis of anti-SB response.

Authors:  N Ohta; N L Reinsmoen; F H Bach
Journal:  Hum Immunol       Date:  1984-11       Impact factor: 2.850

5.  Immune responses during human schistosomiasis mansoni. V. Suppression of schistosome antigen-specific lymphocyte blastogenesis by adherent/phagocytic cells.

Authors:  C W Todd; R W Goodgame; D G Colley
Journal:  J Immunol       Date:  1979-04       Impact factor: 5.422

6.  Factors that modify the cellular-immune response in patients infected by Schistosoma mansoni.

Authors:  R E Rocklin; A P Brown; K S Warren; R P Pelley; V Houba; T K Siongok; J Ouma; R F Sturrock; A E Butterworth
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

7.  Delayed hypersensitivity granuloma formation and modulation around Schistosoma mansoni eggs in vitro. II. Regulatory T cell subsets.

Authors:  B L Doughty; S M Phillips
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Parasite antigen-specific human T cell lines and clones. Major histocompatibility complex restriction and B cell helper function.

Authors:  T B Nutman; E A Ottesen; A S Fauci; D J Volkman
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

9.  Characterization of Schistosoma mansoni antigen-reactive T cell clones that form granulomas in vitro.

Authors:  P J Lammie; G P Linette; S M Phillips
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

10.  Immunopathology of Schistosoma japonicum infection in athymic mice.

Authors:  A W Cheever; J E Byram; F von Lichtenberg
Journal:  Parasite Immunol       Date:  1985-07       Impact factor: 2.280

View more
  1 in total

1.  Regulation of the human T-cell response to Schistosoma japonicum egg antigen by concomitant cellular and humoral mechanisms in vitro.

Authors:  N Ohta; H Asahi; Y Hosaka; M Minai; A Ishii
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.